INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M605. A total of 16 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14 | – | 13,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 17,266 | $23 | 0.00% |
| VANGUARD GROUP INC | 26,246 | $35,432 | 0.00% |
| TD Waterhouse Canada Inc. | 6 | $11 | 0.00% |
| Allworth Financial LP | 1 | $2 | 0.00% |
| Colonial Trust Advisors | 2 | $3 | 0.00% |
| FMR LLC | 73 | $99 | 0.00% |
| WELLS FARGO & COMPANY/MN | 22 | $30 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1 | $1 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% |